Document Security Systems

DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and/or acquire assets and investments in the securities trading and/or funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.

CEO Highlights Business Plan including Spin-Offs CEO Highlights Business Plan including Spin-Offs

DSS Announces Letter to Shareholders

ROCHESTER, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced it received a notice (the "Notice") stating that the Company is not in compliance with the NYSE American's continued listing requirements under the timely filing criteria established in the NYSE American Company Guide. Under Section 1007 of the NYSE American Company Guide, the Company could be granted up to 12 months to cure the late filer deficiency. The initial six month period to regain compliance is automatic and the additional six months is only granted upon request by the Company and approval by the NYSE.

DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

Blue Hat Interactive Entertainment Technology

Boxed

Velo3D

Penny stocks to watch under $5. The post Penny Stocks To Buy This Week?

Penny Stocks To Buy This Week? 4 Under $5 To Watch Before Monday

ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced Global BioLife, Inc. (“Global BioLife”), a subsidiary of the Company's wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”), executed a license agreement with ProPhase BioPharma, Inc. (“PBIO”), a subsidiary of ProPhase Labs, Inc. (Nasdaq: PRPH), a rapidly growing and diversified diagnostics, genomics and biotech company, for Global BioLife's Linebacker portfolio (LB-1 and LB-2), two patented small molecule PIM kinase inhibitors with significant potential across multiple therapeutic indications.

DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs

ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced the expansion of its Board of Directors with the appointment of two independent directors, Frankie Wong, a 20-year veteran of public-company financial reporting, and Joanne Wong Hiu Pan, an investment manager with BMI Funds Management Ltd., the leading financial advisor in Hong Kong.

DSS Strengthens and Expands Board with Appointment of Two Independent Directors

HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research and Discovery Group Sciences (GRDG), announced today that it signed a license agreement with ProPhase Labs (NASDAQ: PRPH) for Equivir, which has shown potential as a treatment to limit the occurrence of or reduce the risk or severity of viral outbreaks.

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

China is one of the leading markets globally for insect repellants China is one of the leading markets globally for insect repellants

DSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced that an interview with Chief Operating Officer, Jason Grady, will air on The RedChip Money Report® on Bloomberg U.S., this Saturday May 7th, at 7 p.m. Eastern Time (ET). Bloomberg U.S. is available in an estimated 73 million homes across the United States.

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

Clover Health Investments

GSX Techedu Inc.

Here are three penny stocks to add to your watchlist right now The post 3 Hot Penny Stocks to Buy Now? Check These Small-Caps Out  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks to Buy Now? Check These Small-Caps Out

Coeur Mining

CTI BioPharma

Can these penny stocks climb this month? The post Hot Penny Stocks to Watch in March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks to Watch in March 2022

ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by DSS, Inc. (NYSE American: DSS), please note that in paragraph fourteen, [With more than $1.7 trillion in assets…] should read [With more than $1.7 billion in assets…]. The corrected release follows:

CORRECTION - DSS Announces Letter to Shareholders

ROCHESTER, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industries, today announced that it will present a company overview at the Aegis Capital Corp. ("Aegis") Virtual Conference on February 25th at 9:30 a.m. EST. The conference will span three days, starting on February 23rd until February 25th from 8:30 a.m. until 5 p.m. EST.

DSS to Present at Aegis Virtual Conference

ROCHESTER, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industries, entered into a stock purchase agreement (the “Agreement”) with Alset EHome International, Inc. (“AEI”) pursuant to which the Company agreed to issue to up to 44,619,423 shares of the Company's common stock (the “Shares”) for a purchase price of $0.3810 per share. If required by the rules and regulations of the NYSE American, LLC, the issuance of the shares will be subject to the approval of the Company's shareholders.

DSS Receives $17 Million Investment from Alset EHome International

DSS Inc (NYSE: DSS) has entered a stock purchase agreement with its shareholder Alset EHome International Inc. (AEI), which owns 15.24% of its outstanding shares. Under the agreement, AEI sold 877.24 million ordinary shares of Alset International Limited to DSS for a purchase price of ~59.98 million newly issued shares of DSS's common stock.

DSS Shareholder Alset EHome To Raise Stake To 55.52%

DSS adds True Partner Capital with $1.7B AUM into DSS Securities; greatly enhancing the portfolio of the finance and asset management division of DSS

DSS Acquires 25.1% of Alset International Limited

Six years remaining on lease for primary tenant at Winter Haven, Florida property Six years remaining on lease for primary tenant at Winter Haven, Florida property

DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building

ROCHESTER, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS) along with its scientific research partner Global Research and Discovery Group Sciences, (GRDG) announced today a project that is designed to take plastics in a whole new direction with the development of what we call Bio-plastics. Bio-plastics under development are designed to make everyday objects resistant to viruses, and also gentler to the planet.

Impact BioMedical Announces New Bioplastics Test Results

GEE Group

Sesen Bio Inc.

SNDL Inc.

Surgalign Holdings, Inc.

Waitr Holdings Inc

These penny stocks trading for under $1 per share all have strong chances of delivering stunning returns in the coming year. The post 6 of the Best Penny Stocks Under $1 to Buy Now for 2022 appeared first on InvestorPlace.

6 of the Best Penny Stocks Under $1 to Buy Now for 2022

New 105,000 sq. ft. facility more than doubles Premier's capacity to produce sustainable fiber-based packaging solutions for a wide variety of consumer products New 105,000 sq. ft. facility more than doubles Premier's capacity to produce sustainable fiber-based packaging solutions for a wide variety of consumer products

DSS Provides Update on Expansion of Premier Packaging Subsidiary

ROCHESTER, N.Y., Dec. 20, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industries, is pleased to announce its American Pacific Bancorp, Inc. (“APB”) subsidiary has issued nearly $20 million in new loans since September 2021.

DSS's American Pacific Bancorp Approaches $20M in New Loans Issued

ROCHESTER, N.Y., Dec. 15, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced the opening of a new office in Sacramento, California to serve as the home office for DSS Wealth Management Inc. (“DSS Wealth Management”) and DSS AmericaFirst Quantitative Funds (“DSS AmericaFirst”).

DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds

ROCHESTER, N.Y., Dec. 07, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced that it has been invited to present at the Emerging Growth Conference on December 8, 2021 at 2:30 p.m. ET.

DSS to Present at the Emerging Growth Conference on December 8

ROCHESTER, N.Y., Nov. 30, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced the launch of DSS AmericaFirst Quantitative Funds.

DSS Enters Quantitative Investment Fund Arena

ROCHESTER, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced its majority-owned subsidiary, American Medical REIT Inc. ("AMRE"), has acquired three hospitals (the “Hospitals”) located in Fort Worth, Texas, Plano, Texas and Pittsburgh, Pennsylvania. The aggregate purchase price for the Hospitals was $62 million. The Hospitals are currently tenanted and operated by LifeCare Hospitals (together with its affiliates, “LifeCare Hospitals”), a specialty hospital operator with a focus on long-term acute and critical care.

DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania

ROCHESTER, N.Y., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced it is changing its name to DSS, Inc. The name change will become effective on September 30, 2021.

News for Document Security Systems Stock (DSS)